Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia [NA]

View source ↗

Summary

This clinical trial compares VENEZE Peptide Factor Hair Serum with 2% topical minoxidil for androgenetic alopecia and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MINOXIDIL (Minoxidil)
  • VENEZE Peptide Factor Hair Serum

Snippet

Sponsor: Institute of Dermatology, Thailand | Conditions: Androgenetic Alopecia (AGA) | NA | Status: NOT_YET_RECRUITING